Literature DB >> 962990

Association of medullary carcinoma of the thyroid with carcinoembryonic antigen.

N Ishikawa, S Hamada.   

Abstract

To investigate the association between medullary carcinoma of the thyroid (MCT) and carcinoembryonic antigen (CEA), we assayed 78 sera from patients with thyroid diseases for CEA, employing the radioimmunoassay of double antibody technique. All 13 sera from patients with MCT had high levels of CEA, ranging from 14 to 170 ng/ml. Increased serum CEA was noted even in cases of small, localized carcinoma. By contrast, serum CEA levels were normal (below 10 ng/ml) in all other histological types of thyroid carcinoma (33 cases), except for one case of papillary adenocarcinoma. In 32 patients with non-malignant thyroid diseases, with few exceptions serum CEA levels remained within the normal range. The elevated serum levels of CEA in MCT returned to normal after successful operation. Furthermore, very high tissue concentrations of CEA were demonstrated in MCT. The results indicate that CEA is actively produced by MCT, and that its measurement is useful in the diagnosis and management of the disease. It is suggested that the highly specific association of CEA with MCT may well be related to a defect of neural crest origin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 962990      PMCID: PMC2025162          DOI: 10.1038/bjc.1976.133

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

Review 1.  Studies in familial (medullary) thyroid carcinoma.

Authors:  K E Melvin; A H Tashjian; H H Miller
Journal:  Recent Prog Horm Res       Date:  1972

Review 2.  The neural ectodermal origin of the peptide-secreting endocrine glands. A unifying concept for the etiology of multiple endocrine adenomatosis and the inappropriate secretion of peptide hormones by nonendocrine tumors.

Authors:  R F Weichert
Journal:  Am J Med       Date:  1970-08       Impact factor: 4.965

3.  Carcinoembryonic antigen in patients with different cancers.

Authors:  G Reynoso; T M Chu; D Holyoke; E Cohen; T Nemoto; J J Wang; J Chuang; P Guinan; G P Murphy
Journal:  JAMA       Date:  1972-04-17       Impact factor: 56.272

4.  Carcinoembryonic antigen and humoral antibody response in patients with thyroid carcinoma.

Authors:  H Rochman; L J deGroot; C H Rieger; L A Varnavides; S Refetoff; J I Joung; K Hoye
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

5.  Serum carcinoembryonic antigen in clinical disorders.

Authors:  S N Booth; J P King; J C Leonard; P W Dykes
Journal:  Gut       Date:  1973-10       Impact factor: 23.059

6.  The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system.

Authors:  D M Thomson; J Krupey; S O Freedman; P Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

7.  Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma.

Authors:  D J Laurence; U Stevens; R Bettelheim; D Darcy; C Leese; C Turberville; P Alexander; E W Johns; A M Neville
Journal:  Br Med J       Date:  1972-09-09

Review 8.  Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review.

Authors:  D J Laurence; A M Neville
Journal:  Br J Cancer       Date:  1972-10       Impact factor: 7.640

9.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

  9 in total
  14 in total

1.  99mTc(V)-dimercaptosuccinic acid scintigraphy for medullary thyroid carcinoma.

Authors:  A Miyauchi; K Endo; H Ohta; K Torizuka; F Matsuzuka; A Kobayashi; K Kuma; M Maeda
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

Review 2.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

3.  Carcinoembryonic antigen in thyroid cancer.

Authors:  M Cimitan; B Busnardo; M E Girelli; D Casara; G P Zanatta
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

4.  Carcinoembryonic antigen assay in thyroid screening.

Authors:  K Shimaoka; T M Chu
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

5.  Carcinoembryonic antigen in thyroid disease.

Authors:  J Economidou; P Karacoulis; O N Manousos; E Manesis; A Kydonakis; D A Koutras
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

6.  Human medullary thyroid carcinoma in tissue culture; secretion of calcitonin and carcinoembryonic antigen.

Authors:  R Oosterom; T Verleun; H A Bruining; W H Hackeng; S W Lamberts
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

7.  Metastatic C-cell carcinoma: calcitonin and CEA production in monolayer culture.

Authors:  W Schurr; E Rix; H Schmidt-Gayk; F Raue; R Ziegler
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

8.  Serum tissue polypeptide antigen (TPA) in thyroid cancer.

Authors:  E Martino; G Bambini; F Aghini-Lombardi; E Motz; F Pacini; R Lari; L Baschieri; A Pinchera
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256

9.  Bone and Calcified Soft Tissue Metastases of Medullary Thyroid Carcinoma Better Characterized on 18F-Fluoride PET/CT than on 68Ga-Dotatate PET/CT.

Authors:  Paulo Schiavom Duarte; Luciana Audi de Castroneves; Heitor Naoki Sado; Marcelo Tatit Sapienza; Ana Amélia Fialho de Oliveira Hoff; Carlos Alberto Buchpiguel
Journal:  Nucl Med Mol Imaging       Date:  2018-06-04

Review 10.  The detection and evaluation of human tumor metastases.

Authors:  D J Laurence; A M Neville
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.